Alimera Sciences (ALIM) Misses Q3 EPS by 1c

Alimera Sciences (NASDAQ: ALIM) reported Q3 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $23.4 million versus the consensus estimate of $23.8 million.

For earnings history and earnings-related data on Alimera Sciences (ALIM) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
• zSpace, Inc. (ZSPC) Reports Q2 results